Semergen · 2026
Cardiovascular risk factors and their evolution in a primary care psoriasis cohort: The REPICA study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Heras-Hitos J A, Segura-Fragoso A, Polo García J, Cinza-Sanjurjo S, Montes-Belloso M E, Velilla-Zancada S, Palacios-Martínez D, Pérez-Simón A, Vale-Varela C, Martínez Guillamón M R, Rincón Ricote A I, Pallarés-Carratalá V
Аннотация
OBJECTIVE: To determine the incidence and evolution of cardiovascular risk factors in patients with psoriasis managed in a primary care setting in Spain, and to explore the occurrence of cardiovascular events and mortality during follow-up.
METHODS: Observational, longitudinal, multicenter, prospective study including patients ≥45 years with psoriasis attended in primary care in Spain. Participants were enrolled between May 2019 and May 2021 and followed annually. Incidence rates (per 1000 patients/year) of cardiovascular risk factors were estimated. Cardiovascular events and mortality were analyzed as exploratory outcomes.
RESULTS: A total of 422 subjects were included (mean age 61.1 years; 51.4% male). At baseline, cardiovascular risk factors were highly prevalent (dyslipidemia 55%, hypertension 49%, diabetes 21%). Among patients with at least one follow-up visit (n=179; median follow-up 1.55 years), incidence rates per 1000 person-years were 49.05 for dyslipidemia, 30.48 for hypertension, 30.44 for obesity, and 14.90 for diabetes. Most patients showed stable psoriasis over time (∼80%). Exploratory analyses showed limited numbers of cardiovascular events and deaths, precluding robust inference.
CONCLUSIONS: Patients with psoriasis managed in primary care present a high burden and incidence of cardiovascular risk factors, which may develop over a relatively short follow-up period. These findings support the importance of early detection and adequate management of cardiovascular risk in this population.
METHODS: Observational, longitudinal, multicenter, prospective study including patients ≥45 years with psoriasis attended in primary care in Spain. Participants were enrolled between May 2019 and May 2021 and followed annually. Incidence rates (per 1000 patients/year) of cardiovascular risk factors were estimated. Cardiovascular events and mortality were analyzed as exploratory outcomes.
RESULTS: A total of 422 subjects were included (mean age 61.1 years; 51.4% male). At baseline, cardiovascular risk factors were highly prevalent (dyslipidemia 55%, hypertension 49%, diabetes 21%). Among patients with at least one follow-up visit (n=179; median follow-up 1.55 years), incidence rates per 1000 person-years were 49.05 for dyslipidemia, 30.48 for hypertension, 30.44 for obesity, and 14.90 for diabetes. Most patients showed stable psoriasis over time (∼80%). Exploratory analyses showed limited numbers of cardiovascular events and deaths, precluding robust inference.
CONCLUSIONS: Patients with psoriasis managed in primary care present a high burden and incidence of cardiovascular risk factors, which may develop over a relatively short follow-up period. These findings support the importance of early detection and adequate management of cardiovascular risk in this population.